TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G(1)- to S-phase transition

Yi-Dong Wang1, Guo-Hui Bian, Xiao-Yan Lv

  • 1Core Facility of Gene Engineered Mouse, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China.

BMB Reports
|October 31, 2008
PubMed

Insights

TC1 (C8orf4) is upregulated by mitogens via the ERK1/2 pathway. Overexpressing TC1 promotes cell cycle progression from G1 to S phase, revealing a novel mechanism in cell proliferation regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Previous studies suggest TC1 (C8orf4) involvement in cancer cell proliferation.
  • The precise molecular mechanisms underlying TC1's role remain largely unelucidated.

Purpose of the Study:

  • To investigate the regulation of TC1 mRNA levels by mitogens.
  • To elucidate the role of TC1 in cell cycle progression.
  • To determine the involvement of the ERK1/2 signaling pathway in TC1-mediated effects.

Main Methods:

  • Analysis of TC1 mRNA levels in response to mitogens (FBS/thrombin).
  • Investigation of the ERK1/2 signaling pathway's role using fibroblast cells.
  • Luciferase reporter assays to assess Cyclin D1 promoter activity.

Main Results:

  • TC1 mRNA levels were upregulated by mitogens, partly via the ERK1/2 pathway.
  • TC1 overexpression promoted the G(1)- to S-phase transition.
  • ERK1/2 signaling deficiency delayed TC1-induced cell cycle progression.
  • TC1 overexpression enhanced Cyclin D1 promoter activity.

Conclusions:

  • TC1 is implicated in the mitogen-activated ERK1/2 signaling pathway.
  • TC1 positively regulates the G(1)- to S-phase transition of the cell cycle.
  • These findings offer a novel mechanistic insight into TC1's function in cell proliferation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...